Key facts
- Magicpen Bio’s last known valuation is $21.2M (Oct 2024).
- It has raised $1.4M; the latest was Early Stage VC in Feb 2026.
- Notable investors include Plum Ventures, Confitop Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Magicpen Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Magicpen Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Magicpen Bio
Developer of high-throughput gene-editing technology based in China. The company offers advanced plant gene improvements and creates high-brightness glowing plants, thereby supporting agricultural production.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2023
- Website
- magicpenbio.com/
- Ownership
- Privately Held (backing)
Magicpen Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magicpen Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magicpen Bio in its N-PORT filings yet. We sweep new filings monthly.